Cardiometabolic risk algorithm for patients with ACS: a precision health strategy to reduce residual cardiovascular risk
.jpg)
A multinational randomized controlled trial (RCT) on optimized risk factor management after acute coronary syndromes (ACS) using a novel algorithm for predicting residual cardiovascular risk, developed by Dr. Florian A. Wenzl, has initiated enrollment.
The trial is funded by the EU HORIZON program and may inform novel drug-based treatment strategies for intensified risk factor modification in patients with ACS to reduce adverse cardiovascular events occurring despite standard medical therapy.